“Our findings fit within the broader literature showing that improved access to symptom-relieving treatments can affect labor market outcomes.”
Archives: News Releases
Since 1992, every Thursday and when breaking news warrants, NORML | The NORML Foundation have been issuing weekly press releases for marijuana law supporters and the media.
NORML’s News Releases archives goes back to 1996 and serves as a valuable tool to alert citizens about cannabis-related news and legislation as well as a research tool for reviewing a chronology of marijuana law reform.
“Cannabis-based medicines may offer an alternative to traditional treatments,” researchers concluded.
Market demand for legal cannabis products has remained steady while wholesale prices have fallen.
“Cannabis use for sleep is rising in popularity in the United States,” the study’s authors concluded.
The record sealing process is not automatic, and eligible parties will need to file a request with the requisite state agencies to have their records sealed.
“This trial provides, for the first time, evidence that CBD taken at a relatively high dose can reduce self-reported pain intensity in individuals with chronic neuropathic pain.”
The FDA’s decision follows the results of a Phase 3 clinical trial concluding that patients who consumed the cannabis extract experienced greater mean pain reductions than did those who took opioids.
“This legislation modernizes Illinois’ cannabis regulation by bringing the much-needed reforms that patients, consumers, and industry have been asking for.”